As of March 2024 Viatris has a market cap of $14.17 Billion. This makes Viatris the world's 1253th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $14.17 B | 9.14% |
2023 | $12.99 B | -3.74% |
2022 | $13.49 B | -17.51% |
2021 | $16.36 B | -27.65% |
2020 | $22.61 B | 118.01% |
2019 | $10.37 B | -26.59% |
2018 | $14.13 B | -37.73% |
2017 | $22.69 B | 11.18% |
2016 | $20.41 B | -23.05% |
2015 | $26.52 B | 25.42% |
2014 | $21.15 B | 31.15% |
2013 | $16.12 B | 48.66% |
2012 | $10.84 B | 18.52% |
2011 | $9.15 B | -0.67% |
2010 | $9.21 B | 63.14% |
2009 | $5.64 B | 87.44% |
2008 | $3.01 B | -29.58% |
2007 | $4.27 B |
On Mar 27th, 2024 the market cap of Viatris was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.83 B | -94.10% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $21.21 M | -99.85% | ๐บ๐ธ USA |